Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study-Reference-Cited by-同舟云学术

Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study

Published:2016-04-04 Issue:9 Volume:46 Page:1317-1323
ISSN:0301-0449
Container-title:Pediatric Radiology
language:en
Short-container-title:Pediatr Radiol

Author:

Glutig Katja, ,Bhargava Ravi,Hahn Gabriele,Hirsch Wolfgang,Kunze Christian,Mentzel Hans-Joachim,Schaefer Jürgen F.,Willinek Winfried,Palkowitsch Petra

Funder

Bayer Pharma

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00247-016-3599-6.pdf

Reference26 articles.

1. Scott LJ (2013) Gadobutrol: a review of its use for contrast-enhanced magnetic resonance imaging in adults and children. Clin Drug Investig 33:303–314

2. Kunze C, Mentzel HJ, Krishnamurthy R (2015) Pharmacokinetics and safety of macrocyclic gadobutrol in children 0 to <2 years of age and comparison to older populations. Invest Radiol 51:50–57

3. Port M, Corot C, Violas X et al (2005) How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity. Invest Radiol 40:565–573